Guidance, NICE advice and quality standards In development

Skip to filtersSkip to results

Skip to results

Expected publication date

Expected publication date

Area of interest

Area of interest

Type 2 selected

Type

Guidance programme

Showing 1 to 25 of 382

TitleTypeExpected publication date
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]Technology appraisal guidanceTBC
Abaloparatide for treating osteoporosis in postmenopausal women [ID882]Technology appraisal guidanceTBC
Abatacept for preventing moderate to severe acute graft-versus-host disease after haematopoietic stem cell transplant in people 6 years and over [ID6185]Technology appraisal guidanceTBC
Abicipar pegol for treating wet age-related macular degeneration ID1533Technology appraisal guidanceTBC
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]Technology appraisal guidanceTBC
Acute Respiratory Infection in over 16s: Initial assessment and managementNICE guideline
Acute respiratory infection in over 16s: initial assessment and management, including using virtual wardsQuality standard
Adrenal insufficiency: acute and long-term managementNICE guideline
Alcohol-mediated perivascular renal denervation for resistant hypertensionInterventional procedures guidance
Algorithm-based remote monitoring of heart failure risk data in people with cardiac implantable electronic devicesDiagnostics guidance
Alzheimer's disease (early) - gantenerumab [ID6142]Technology appraisal guidanceTBC
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]Highly specialised technologyTBC
Artificial intelligence (AI) software to help clinical decision making in strokeDiagnostics guidance
Artificial Intelligence for dermatology - skin cancer: reduce referrals by early detection of benign skin lesions (provisional title)Diagnostics guidanceTBC
Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessmentHealth technology evaluation
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessmentHealth technology evaluationTBC
Asthma: diagnosis, monitoring and chronic asthma managementNICE guideline
Asunercept for treating glioblastoma [1301]Technology appraisal guidanceTBC
Atezolizumab (Tecentriq) + bevacizumab (Avastin) + chemotherapy for ovarian cancer TS ID 10701Technology appraisal guidanceTBC
Atezolizumab for adjuvant treatment of renal cell carcinoma with a high risk of metastasis [ID5101]Technology appraisal guidanceTBC
Atezolizumab for adjuvant treatment of resected high-risk muscle-invasive urothelial cancer [ID2730]Technology appraisal guidanceTBC
Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor [ID6213]Technology appraisal guidanceTBC
ATIR101 with haploidentical haematopoietic stem cell transplantation for haematological cancers [ID1093]Technology appraisal guidanceTBC
Atogepant for preventing migraine [ID5090]Technology appraisal guidanceTBC
Aumolertinib for untreated EGFR mutation-positive non-small-cell lung cancer [ID4000]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All